AMRX Amneal Pharmaceuticals, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AMRX Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
Current Price
Live
$11.83
Analyst Target
$16.8
+42.0%
Upside
52W High
$15.42
52W Low
$6.68
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
AMRX's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and profitability consistency. The absence of an Altman Z-Score and a Debt/Equity ratio of 450.96 suggest extreme leverage and significant bankruptcy risk. Despite strong earnings surprises and robust revenue growth, the stock trades at a forward P/E of 10.12 but carries a negative Price/Book of -52.58, indicating deep value distortion. The lack of dividends, bearish insider activity, and technical trend further undermine investor confidence. The intrinsic value estimate of $1.54 is vastly below the current price of $11.83, highlighting severe overvaluation.
Key Strengths
Strong revenue growth of 11.50% YoY
Consistently beating earnings estimates in 3 of the last 4 quarters
High average earnings surprise of 26.64% over the last 4 quarters
Positive year-over-year EPS growth of 75.0%
Strong Q/Q EPS growth of 23.5%
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Debt/Equity ratio of 450.96 is dangerously high, signaling extreme leverage
Negative Price/Book ratio of -52.58 suggests asset value erosion or accounting anomalies
No Altman Z-Score available, but the extreme leverage implies distress risk
Bearish insider sentiment with $2.16M in sales and zero buys in the last 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$1.54
-87.0% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AMRX against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AMRX from our newsroom.
Newest → oldest
No matching news yet.